George E Davis, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 705 S University Ave, Suite 100, Beaver Dam, WI 53916 Phone: 920-887-1151 Fax: 920-887-3353 |
Erik O Schoff, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 240 Corporate Drive, Beaver Dam, WI 53916 Phone: 920-887-1151 Fax: 920-887-3353 |
Thomas A Castillo, DO Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 240 Corporate Drive, Beaver Dam, WI 53916 Phone: 920-887-1151 Fax: 920-887-3353 |
Omar Abdelmegid, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 707 S University Ave, Beaver Dam, WI 53916 Phone: 920-887-7181 |
Jay M Wilkins, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 240 Corporate Drive, Beaver Dam, WI 53916 Phone: 920-887-1151 Fax: 920-887-3353 |
News Archive
In this post in the Center for Global Development's "Global Health Policy" blog, Mead Over, a senior fellow at the center, follows up on a post last week in which he wrote that a panel of senior economists commissioned by the Rush Foundation was to address the question of how to spend an additional, but hypothetical, $10 billion on HIV/AIDS programs in Africa over the next five years.
Quest Diagnostics Incorporated announced today that The University of Texas M. D. Anderson Cancer Center in Houston has granted the company exclusive use of five proprietary blood testing methods, which, once available in the form of laboratory diagnostic tests, may eliminate the need for painful and expensive bone marrow and other tissue extractions.
Researchers at the University of Pennsylvania School of Medicine have helped develop a technique in animal models for using the abdominal cavity to exchange gas, supplementing the function normally performed by the lungs.
Scientists have shown that people who exercise for even a few hours each week can enlarge their hearts. This is a normal and beneficial response to exercise, but until now has only been recognised in athletes.
Inflammatory breast cancer is a very aggressive type of cancer associated with early metastasis and poor survival rates, and the prognosis is even worse for patients with tumors expressing the ErbB2 receptor. The ErbB2-inhibiting drug lapatinib can slow the spread of cancer cells in individuals with advanced breast cancer who have already tried other chemotherapy medications.
› Verified 7 days ago